Search
for

    Sort by

    Research 61–90 of 167

    1. Telogen Effluvium Archives of Dermatology · 1993 · 214 citations
    2. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania American Journal of Psychiatry · 1991 · 180 citations
    3. Neural Mechanisms of Hair Growth Control Journal of Investigative Dermatology Symposium Proceedings · 1997 · 101 citations
    4. ς<sub>1</sub>Receptor-Related Neuroactive Steroids Modulate Cocaine-Induced Reward Journal of Neuroscience · 2003 · 100 citations
    5. Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders Current Pharmaceutical Design · 2011 · 72 citations
    6. Stability of opiates in hair fibers after exposure to cosmetic treatment Forensic Science International · 1996 · 63 citations
    7. Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease Movement Disorders · 2011 · 47 citations
    8. A preliminary study of finasteride in Tourette syndrome Movement Disorders · 2011 · 46 citations
    9. Hair cycle control by leptin as a new anagen inducer Experimental Dermatology · 2013 · 41 citations
    10. Comprehensive analysis of circRNAs from cashmere goat skin by next generation RNA sequencing (RNA-seq) Scientific Reports · 2020 · 39 citations
    11. Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up Movement Disorders · 2011 · 39 citations
    12. Shedding: How to manage a common cause of hair loss Cleveland Clinic Journal of Medicine · 2001 · 34 citations
    13. 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction Neurobiology of Disease · 2018 · 26 citations
    14. Female Adolescent Hair Disorders Journal of Pediatric and Adolescent Gynecology · 2009 · 20 citations
    15. Systemic causes of hair loss Annals of Medicine · 2016 · 18 citations
    16. Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies Movement Disorders · 2011 · 17 citations
    17. Development of a new GC–MS/MS method for the determination of metformin in human hair Drug Testing and Analysis · 2020 · 14 citations
    18. Carbamazepine-Induced Hair Loss Dicp-The annals of pharmacotherapy · 1985 · 12 citations
    19. Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats Neuropharmacology · 2018 · 10 citations
    20. Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study Swiss Medical Weekly · 2025 · 8 citations
    21. Involvement of the central hypothalamic-pituitary-adrenal axis in hair growth and melanogenesis among different mouse strains PLoS ONE · 2018 · 6 citations
    22. Medical consequences of long-term anabolic-androgenic Steroids (AASs) abuses in athletes Biomedical Research-tokyo · 2017 · 5 citations
    23. Update on psychodermatological disorders Expert Review of Dermatology · 2010 · 5 citations
    24. Restoring neuropetide Y levels in the hypothalamus ameliorates premature aging phenotype in mice GeroScience · 2025 · 4 citations
    25. Effects of non-contingent cocaine on 3alpha-androstanediol. I. Disruption of male sexual behavior Physiology & Behavior · 2019 · 4 citations
    26. Examining polyquaternium polymers deposition on human excised hair fibers Journal of Cosmetic Dermatology · 2017 · 4 citations
    27. Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy Movement Disorders · 2011 · 4 citations
    28. Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target Journal of Medicinal Chemistry · 2021 · 3 citations
    29. Chapter 14 Principles of drug metabolism Principles of Medical Biology · 1997 · 2 citations
    30. Anorexia Nervosa and Bulimia Nervosa Elsevier eBooks · 2009 · 1 citations